@WSJ 2 years ago Pfizer raised its revenue outlook for the year on higher-than-expected sales from its Covid-19 vaccine despite reporting a drop in third-quarter revenue on.wsj.com
@WSJ 3 years ago A Pfizer executive said the Covid-19 vaccine supply chain that developed at the height of the pandemic provides a model for rolling out lifesaving drugs on.wsj.com
@WSJ 3 years ago Pfizer-BioNTech vaccines modified to target Omicron produced stronger immune responses in study subjects than the original Covid-19 shot, the companies say on.wsj.com
@WSJ 3 years ago Pfizer has asked the FDA to authorize its Covid-19 vaccine in children 6 months to 5 years. The three-dose series could be available later this month. on.wsj.com
@WSJ 3 years ago Pfizer asked the FDA to authorize its Covid-19 booster dose for children 5 to 11 years old. The agency is expected to take a couple of weeks to conduct its review, a person familiar with the matter said. on.wsj.com
@nytimesworld 3 years ago Pfizer agreed to sell up to four million treatment courses of its Covid pills for use in 95 lower-income countries. The pills, set to be available next month, will most likely be the first Covid drugs available in some of the poorest parts of the world. nyti.ms
@guardian 3 years ago Covid live: South Korea approves Pfizer vaccine for five-year-olds; UK emergency loan losses hit £16bn theguardian.com
@guardian 3 years ago Pfizer predicts bumper year from Covid vaccine and pill as profits double theguardian.com
@WSJ 3 years ago Breaking: The U.S. cleared use of a Covid-19 pill from Pfizer, the first drug that newly infected patients can now take at home to stay out of the hospital on.wsj.com
@WSJ 3 years ago Pfizer and BioNTech have asked U.S. regulators to fully approve their Covid-19 vaccine for 12- to 15-year-olds on.wsj.com
@WSJ 3 years ago People who had received a third shot of the Pfizer-BioNTech Covid-19 vaccine showed a level of neutralization against the Omicron variant about 100 times higher than those who had received two shots, a new Israeli study found on.wsj.com
@guardian 3 years ago Australia confirms five- to 11-year-old children approved to receive Pfizer Covid vaccine – video theguardian.com
@WSJ 2 years ago Pfizer said it expects to price its Covid-19 vaccine at $110 to $130 a dose for adults when the U.S. government stops purchases on.wsj.com
@WSJ 3 years ago Pfizer and BioNTech began tinkering with their Covid-19 vaccine before new Omicron strains spread in the U.S. The preparations are a big reason the reformulated boosters are rolling out now. on.wsj.com
@WSJ 3 years ago Children as young as six months could get Covid-19 shots as soon as Monday after vaccines from Pfizer and Moderna were cleared for use by the FDA on.wsj.com
@WSJ 3 years ago Here is what parents should know about Covid-19 vaccines and children after Pfizer and BioNTech said three doses of their shot generated a strong immune response and were 80% effective in children 6 months to 5 years https://on.wsj.com/3yT7jl6
@WSJ 3 years ago Vaccine makers Pfizer and Moderna have both named company outsiders as chief financial officers as the companies look to deploy some of the cash they generated during the Covid-19 pandemic https://on.wsj.com/3rgxsWk
@WSJ 3 years ago Pfizer has a deal to sell to Unicef the company’s Covid-19 pill Paxlovid. Unicef plans to provide it to 95 low- and middle-income countries https://on.wsj.com/3L0HQsQ
@WSJ 3 years ago The FDA has asked for more time to decide whether to expand authorization of the Pfizer-BioNTech Covid-19 vaccine to children under 5 years, saying it wants to consider more data https://on.wsj.com/3sDbQ6m
@guardian 3 years ago Pfizer seeks US authorization of Covid vaccine for children under five https://www.theguardian.com/world/2022/feb/01/fda-urges-pfizer-to-apply-for-authorization-of-covid-vaccine-for-children-under-five?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1643763155
@WSJ 3 years ago CDC advisers recommended adults take Pfizer or Moderna Covid vaccines over Johnson & Johnson’s due to a risk of rare clotting cases tied to the J&J shot https://on.wsj.com/3p4oET3
@WSJ 3 years ago CDC advisers recommended adults take Pfizer or Moderna Covid vaccines over Johnson & Johnson’s due to a risk of rare clotting cases tied to the J&J shot https://on.wsj.com/3IZEZ3o
@WSJ 3 years ago Omicron was able to elude two doses of the Covid-19 vaccine from Pfizer and BioNTech in initial lab testing, but three doses neutralized the variant, the companies said https://on.wsj.com/3pHYPXV
@guardian 3 years ago Covid news live: England moves to ‘plan B’; three Pfizer shots can ‘neutralise’ Omicron, lab tests show https://www.theguardian.com/world/live/2021/dec/09/covid-news-live-england-moves-to-plan-b-three-pfizer-shots-can-neutralise-omicron-lab-tests-show?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1639010824
@WSJ 2 years ago Novavax’s Covid-19 vaccine was authorized by the FDA as a booster for adults who don’t want or can’t access or might have medical reasons to avoid the dual-target booster shots from Pfizer or Moderna https://on.wsj.com/3yQBicQ
@WSJ 3 years ago Pfizer is taking steps to maintain its blockbuster Covid-19 product sales, but there were warning signs in the company’s guidance and the rest of the business might not offer much cushion https://on.wsj.com/3oIWziR
@WSJ 3 years ago Children as young as six months could get Covid-19 shots as soon as Monday after vaccines from Pfizer and Moderna were cleared for use by the FDA https://on.wsj.com/3HwtGiu
@guardian 3 years ago Pfizer accused of Covid profiteering as first-quarter sales hit $26bn https://www.theguardian.com/business/2022/may/03/pfizer-covid-sales-pricing-vaccine-paxlovid-pill?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1651585691
@WSJ 3 years ago The CDC backed giving second Covid-19 booster shots from Pfizer and Moderna to adults 50 years and older. Health regulators are expected to authorize the additional shots for the broader population in the fall. https://on.wsj.com/3Lo8WKD
@WSJ 3 years ago Pfizer asked the FDA to authorize a second booster dose of its Covid-19 vaccine for people 65 years and older. Regulators are expected to decide in time for the Biden administration to begin a potential fall vaccine campaign. https://on.wsj.com/3JeLdMn
@WSJ 3 years ago The FDA is expected to release its review of the Pfizer-BioNTech Covid-19 vaccine for children under age 5 as soon as Friday https://on.wsj.com/3LDF1zh
@WSJ 3 years ago Pfizer asked the FDA to authorize its Covid vaccine in children under 5. A booster is under study, as two doses produced a weak immune response in some kids. https://on.wsj.com/3JcvvB9
@WSJ 3 years ago Pfizer pushed back plans to seek authorization of its Covid vaccine in children 2 to 5 years old, after a weaker-than-expected immune response in a study https://on.wsj.com/3yD79MB
@WSJ 3 years ago The first large real-world study of how vaccines hold up against Omicron found that two shots of Pfizer and BioNTech’s Covid-19 vaccine lowered the risk of hospital admission by 70% for patients infected with the highly mutated variant https://on.wsj.com/3EUN72H
@WSJ 3 years ago People who had received a third shot of the Pfizer-BioNTech Covid-19 vaccine showed a level of neutralization against the Omicron variant about 100 times higher than those who had received two shots, a new Israeli study found https://on.wsj.com/3EVzgJu
@BBCWorld 3 years ago Booster Covid jabs promising against Omicron variant, Pfizer and BioNTech say https://bbc.in/3EGaxsk
@WSJ 3 years ago Pfizer and BioNTech asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years https://on.wsj.com/3dNgVpC
@WSJ 3 years ago Pfizer has asked the FDA to approve its Covid pill Paxlovid, a move toward selling the drug commercially, rather than only to the federal government as currently allowed https://on.wsj.com/3a4z9kk
@WSJ 3 years ago Covid vaccines from Pfizer and Moderna were recommended for kids as young as 6 months by FDA advisers. It's the last major group waiting for the shots. https://on.wsj.com/3MWGdx1
@WSJ 3 years ago Investors voted down shareholder proposals urging Pfizer, Moderna and Johnson & Johnson to broaden global access to their Covid-19 vaccines https://on.wsj.com/38y8cEP
@WSJ 3 years ago Second Covid-19 booster shots from Pfizer and Moderna have been authorized by the FDA for adults 50 years and older https://on.wsj.com/38c0tMn
@WSJ 3 years ago Pfizer expects results from its study of the Covid-19 drug Paxlovid in high-risk children by the end of the year https://on.wsj.com/360ua1O
@WSJ 3 years ago Pfizer said surging sales of its Covid-19 treatment and continued demand for its shots should boost the company’s revenue to around $100 billion this year https://on.wsj.com/3ryj6RV
@WSJ 3 years ago The Food and Drug Administration gave its full approval to Moderna's Covid-19 vaccine, branded Spikevax, for use in adults 18 and older, making it the second fully approved Covid-19 vaccine after one from Pfizer and BioNTech https://on.wsj.com/3udpQpU
@guardian 3 years ago T-cells in Pfizer Covid jab recipients stay robust against severe illness https://www.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research?utm_term=Autofeed&CMP=twt_gu&utm_medium&utm_source=Twitter#Echobox=1639761325
@nytimesworld 3 years ago Pfizer said on Tuesday that trials of its Covid pill confirmed that it helped stave off severe disease. A lab study found it worked against Omicron. https://nyti.ms/3pVSYOP
@WSJ 3 years ago Omicron was able to elude two doses of the Covid-19 vaccine from Pfizer and BioNTech in initial lab testing, but three doses neutralized the variant, the companies said https://on.wsj.com/3rRov6X
@guardian 3 years ago Covid live: UK reports 51,342 new infections; three Pfizer shots can ‘neutralise’ Omicron, lab tests show https://www.theguardian.com/world/live/2021/dec/08/covid-live-news-south-korea-surge-sparks-hospital-alarm-stealth-omicron-variant-found?CMP=twt_gu&utm_source=Twitter&utm_medium#Echobox=1638981019